GeneDx Holdings Corp. (NASDAQ:WGSWW – Get Free Report) saw a large decrease in short interest in January. As of January 15th, there was short interest totalling 10,800 shares, a decrease of 60.1% from the December 31st total of 27,100 shares. Based on an average daily trading volume, of 51,600 shares, the days-to-cover ratio is currently […]
GeneDx Holdings Corp. (NASDAQ:WGSWW – Get Free Report) saw a significant drop in short interest in January. As of January 15th, there was short interest totalling 10,800 shares, a drop of 60.1% from the December 31st total of 27,100 shares. Based on an average trading volume of 51,600 shares, the short-interest ratio is currently 0.2 […]
Casdin Capital LLC cut its holdings in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 97.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,095,511 shares of the company’s stock after selling 99,056,274 shares during the quarter. […]
GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) CFO Kevin Feeley sold 2,742 shares of GeneDx stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $4.16, for a total value of $11,406.72. Following the sale, the chief financial officer now directly owns 16,785 shares of […]
GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) CEO Katherine Stueland sold 10,752 shares of the company’s stock in a transaction on Monday, September 18th. The stock was sold at an average price of $4.16, for a total transaction of $44,728.32. Following the completion of the sale, the chief executive officer now owns 42,689 shares […]